Corbin Capital Partners, L.P. - BIOTECH ACQUISITION COMPANY ownership

BIOTECH ACQUISITION COMPANY's ticker is BIOTW and the CUSIP is G1125A116. A total of 39 filers reported holding BIOTECH ACQUISITION COMPANY in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Corbin Capital Partners, L.P. ownership history of BIOTECH ACQUISITION COMPANY
ValueSharesWeighting
Q4 2022$29,654
+5.9%
464,0620.0%0.01%
+28.6%
Q3 2022$28,000
-33.3%
464,0620.0%0.01%
-30.0%
Q2 2022$42,000
-62.2%
464,0620.0%0.01%
-47.4%
Q1 2022$111,000
-63.7%
464,0620.0%0.02%
-64.2%
Q4 2021$306,0000.0%464,0620.0%0.05%
-10.2%
Q3 2021$306,000
-23.3%
464,0620.0%0.06%
-28.9%
Q2 2021$399,000
+7.5%
464,062
-25.0%
0.08%
-4.6%
Q1 2021$371,000618,7490.09%
Other shareholders
BIOTECH ACQUISITION COMPANY shareholders Q2 2021
NameSharesValueWeighting ↓
Radcliffe Capital Management, L.P. 202,950$2,049,7750.06%
RAMIUS ADVISORS LLC 569,526$36,3920.04%
Telemetry Investments, L.L.C. 153,694$100.02%
BOOTHBAY FUND MANAGEMENT, LLC 60,493$610,9730.01%
MARSHALL WACE, LLP 575,000$5,807,5010.01%
Corbin Capital Partners, L.P. 464,062$29,6540.01%
Q Global Advisors, LLC 300,000$190.01%
Segantii Capital Management Ltd 25,000$252,0000.01%
LMR Partners LLP 50,000$504,9950.01%
HGC Investment Management Inc. 2,429,166$1510.01%
View complete list of BIOTECH ACQUISITION COMPANY shareholders